Drugs / IK-3001
last change Jul 2014 re-read 3 minutes ago

IK-3001

Developed for
pulmonary hypertension
Investigated by
Mallinckrodt

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01959828 Sep 2013 → Mar 2014 left ventricular failure, pulmonary hypertension Mallinckrodt Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IK-3001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01959828 ↗